Research Article
Traditional Chinese Medicine Bionic Tiger Bone Powder for the Treatment of AI-Associated Musculoskeletal Symptoms
Table 1
Baseline demographics and clinical characteristics.
| Characteristic | TB () | Placebo () |
| Age, years | | | Median | 55 | 52 | Range | 27–73 | 31–72 | Body mass index | | | Median | 27.6 | 26.7 | Range | 17.5–36.8 | 18.1–35.9 | Menopause | | | Chemically induced (%) | 12 (34.3%) | 11 (31.4%) | Surgically induced (%) | 4 (11.4%) | 2 (5.7%) | Natural (%) | 19 (54.3%) | 22 (62.9%) | Years since menopause | | | Median | 9 | 10 | Range | 0.1–28 | 0.1–26 | Aromatase inhibitor therapy | | | Anastrozole | 21 (60.0%) | 18 (51.4%) | Letrozole | 10 (28.6%) | 11 (31.4%) | Exemestane | 4 (11.4%) | 6 (17.1%) | Pathological state | | | 0 | 2 (5.7%) | 1 (2.9%) | I | 18 (51.4%) | 16 (45.7%) | II | 14 (40.0%) | 15 (42.9%) | III | 1 (2.9%) | 3 (8.6%) | Adjuvant chemotherapy | 25 (71.4%) | 21 (60.0%) | Adjuvant taxane | 13 (37.1%) | 8 (22.9%) |
|
|